CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway
Jiewen Chen(Sun Yat-sen University), Yan Nie(Sun Yat-sen University), Erwei Song(Sun Yat-sen University), Xiyun Yan(Zhongyuan University of Technology), Wende Li(Lanzhou Jiaotong University), Rong Lei(Sun Yat-sen University), Qingji Xu(Chinese Academy of Sciences), Phei Er Saw(Sun Yat-sen University), Dan Liu(Machine Intelligence Research Institute), Xun� Li(Beijing University of Chinese Medicine), Hongyan Huang(Aerospace Research Institute of Materials and Processing Technology), Xuehui Chen(Chinese Academy of Sciences), Mingyan Guo(Sun Yat-sen University)
Cited by 16
Related Papers
Matching the kinetics of natural enzymes with a single-atom iron nanozyme
|Nature Catalysis|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
|Molecular Cancer|2011|700
Nanozymes: A clear definition with fuzzy edges
|Nano Today|2021|559
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
|Clinical Cancer Research|2009|435